| Authors: |
Sharma MR; START Center for Cancer Research-Midwest, Grand Rapids, MI., Powderly J; Carolina BioOncology Institute, Huntersville, NC., Kuboki Y; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan., Strickler JH; Duke University Medical Center, Durham, NC., Perets R; Rambam Medical Center and Technion-Israel Institute of Technology, Haifa, Israel., Cohen JE; Hadassah Hebrew University Medical Center, Jerusalem, Israel., Raimbourg J; Institut de Cancérologie de l'Ouest, Saint Herblain, France., Nakajima TE; Kyoto University Graduate School of Medicine, Kyoto-Shi, Japan., Yamamoto N; National Cancer Center Hospital, Tokyo, Japan., Cruz-Correa M; The University of Puerto Rico, Medical Sciences Campus, and Pan-American Center for Oncology Trials, San Juan, Puerto Rico., O'Neil B; Oncology, Community Health Network North Cancer Center, Indianapolis, IN., Ghiringhelli F; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France., Raghav K; The University of Texas MD Anderson Cancer Center, Houston, TX., Cecchini M; Yale University School of Medicine, New Haven, CT., Bar J; Jusidman Cancer Center, Sheba Medical Center, Ramat Gan, Israel.; The Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Hunter Z; AbbVie Inc, North Chicago, IL., Burns M; AbbVie Inc, North Chicago, IL., Blaney M; AbbVie Inc, North Chicago, IL., Morrison-Thiele G; AbbVie Inc, North Chicago, IL., Aristide MN; AbbVie Inc, North Chicago, IL., Freise KJ; AbbVie Inc, North Chicago, IL., Li R; AbbVie Inc, North Chicago, IL., Li M; AbbVie Inc, North Chicago, IL., Vasilopoulos A; AbbVie Inc, North Chicago, IL., Biesdorf C; AbbVie Inc, North Chicago, IL., Sommerhalder D; NEXT Oncology, San Antonio, TX. |
